Tannia Tembo

Dados Biográficos

ID7789838
NOMETannia Tembo
PRENOMESTannia
SOBRENOMETembo
ASSINATURATEMBO T
AFILIAÇÕESCentre for Infectious Disease Research in Zambia
ORCID0000-0003-3800-371X
VERIFICADOSim
TOTAL DE OBRAS4
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2024
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H0

  • Differentiated community-based point-of-care early infant diagnosis to improve HIV diagnosis and ART initiation among infants and young children in Zambia

    Open AccessAlbert Manasyan, Tannia Tembo et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: An estimated 800 000 children (<15 years) globally living with HIV remain undiagnosed. To reach these children with timely HIV testing services during infancy, we implemented a community-based differentiated care model using mobile point-of-care (POC) technology for early infant diagnosis (EID) of HIV, and assessed its effects on EID positivity, antiretroviral therapy (ART) initiation and 3-month retention in care. METHODS: Between …

  • Implementing Sars-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022

    Open AccessTannia Tembo, Elizabeth Heilmann et al.ARTICLEBMC Public Health2025

    Incorporating SARS-CoV-2 surveillance into routine antenatal care is feasible and potentially sustainable when existing health system infrastructure, human resources, and surveillance systems are leveraged. Yet, careful planning is needed to anticipate implementation challenges and ensure high-quality data collection

  • Covid-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021–2022

    Open AccessTannia Tembo, Paul Somwe et al.ARTICLEPLOS Global Public Health2024

    Pregnant women are considered a high-risk group for COVID-19, and a priority for vaccination. Routine antenatal care (ANC) provides an opportunity to track trends and factors associated with vaccine uptake. We sought to evaluate COVID-19 vaccine uptake among pregnant women attending ANC and assess the factors associated with vaccine in Zambia. We conducted a repeated cross-sectional study in 39 public health facilities in four districts in Zambia…

  • Trends in Sars-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia

    Open AccessElizabeth Heilmann, Tannia Tembo et al.ARTICLEPLOS Global Public Health2024

    SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess exposure trends over time in Zambia. We conducted repeated cross-sectional SARS-CoV-2 seroprevalence surveys among pregnant women aged 15–49 years attending their first ANC visits in four districts of Zambia (two urban and two rural) during September 2021-S…